Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
Read Article
News
2021
2020
Archive
December 16, 2020
Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
December 15, 2020
NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020
Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz as Executive Vice President of Technical Operations
December 14, 2020
Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
December 11, 2020
Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD)
December 8, 2020
Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes™ Trial of DSG3-CAART for Treatment of Mucosal-Dominant Pemphigus Vulgaris
December 8, 2020
Enliven Therapeutics Launches with Vision of Advancing Medicine and Restoring Lives
December 8, 2020
Pear Therapeutics Completes $80M Series D Financing Led By SoftBank Vision Fund 2
December 8, 2020
Entrada Therapeutics Strengthens Leadership Team with Key Appointments
December 7, 2020
Artiva Biotherapeutics Announces FDA Allowance of IND to Initiate Clinical Trials of AB-101 in Combination with Rituximab for the Treatment of Advanced B-cell Lymphomas
1
2
3
…
14
Next Page »
